| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/16/2002 | WO2001079155A3 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| 05/16/2002 | WO2001076638A3 Compositions for drug delivery |
| 05/16/2002 | WO2001075109A3 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 05/16/2002 | WO2001070953A3 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 05/16/2002 | WO2001070662A3 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 05/16/2002 | WO2001069261A3 Proteins, genes and their use for diagnosis and treatment of vascular dementia |
| 05/16/2002 | WO2001049654A3 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 05/16/2002 | WO2001047928A3 Imidazo 1,3,5 triazinones and the use thereof |
| 05/16/2002 | WO2001045663A3 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION |
| 05/16/2002 | WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/16/2002 | US20020058983 Methods for implanting cells |
| 05/16/2002 | US20020058838 Substituted benzenesulfonylureas and -thioureas-processes for their preparation and their use as pharmaceuticals |
| 05/16/2002 | US20020058813 Spiro-indolines as Y5 receptor antagonists |
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/16/2002 | US20020058710 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure |
| 05/16/2002 | US20020058708 Compositions containing hypotriglyceridemically active stilbenoids |
| 05/16/2002 | US20020058705 For use in therapy of hypercholesterolemia, as anti- ischemic and/or anti-thrombotic agent, as antiplatelet agent, or as agent against gastric ulcers induced by compounds, agents or drugs |
| 05/16/2002 | US20020058700 Ion channel modulating agents |
| 05/16/2002 | US20020058692 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 05/16/2002 | US20020058687 For therapy and prohylaxis of inflammatory diseases including joint inflammation, Crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (COPD) including asthma, chronic bronchitis |
| 05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 05/16/2002 | US20020058671 Neuropeptide Y antagonists |
| 05/16/2002 | US20020058667 Compounds specific to adenosine A1 receptors and uses thereof |
| 05/16/2002 | US20020058663 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 05/16/2002 | US20020058657 2-[1H]-quinolone and 2-[1H]-quinoxalone inhibitors of factor Xa |
| 05/16/2002 | US20020058644 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/16/2002 | US20020058629 S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 05/16/2002 | US20020058619 Ligand for vascular endothelial growth factor receptor |
| 05/16/2002 | US20020058336 Controlling cell binding; obtain target cell, incubate with substrate, monitor cell binding |
| 05/16/2002 | US20020058259 Regulation of human lipoxin A4 receptor-like protein |
| 05/16/2002 | US20020058066 Outer layer portion containing cilostazol, a water-insoluble substance, such as ethyl cellulose, and a hydrophilic hydrogel forming substance, such as hydroxypropyl methyl cellulose. |
| 05/16/2002 | US20020058036 Novel fibroblast growth factor and nucleic acids encoding same |
| 05/16/2002 | US20020058029 Anti-CD40L, anti-B7.1 (CD80), anti-B7.2(CD86), CD40 antibody or anti-CD4 antibody; both may be administered separately or in combination, and in any order. |
| 05/16/2002 | US20020058023 Apoptotic bodies and/or apoptotic cells are in a liquid suspension along with viable cells. |
| 05/16/2002 | US20020058022 Novel compounds |
| 05/16/2002 | DE10054279A1 Verwendung von Liganden von Todesrezeptoren oder RIP zur Auslösung des Caspase-unabhängigen Zelltods und Verbindungen zur Inhibition des Caspase-unabhängigen Zelltods Use of ligands of death receptors or RIP to trigger the caspase-independent cell death and compounds for inhibition of the caspase-independent cell death |
| 05/16/2002 | CA2428784A1 Oral pharmaceutical composition containing a block copolymer |
| 05/16/2002 | CA2428179A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 05/16/2002 | CA2428176A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | CA2428159A1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide |
| 05/16/2002 | CA2428114A1 Apolipoprotein analogues |
| 05/16/2002 | CA2427774A1 Inhibitors of thromboxane formation and action |
| 05/16/2002 | CA2427757A1 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | CA2426049A1 Improved treatment |
| 05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | CA2426030A1 Methods of treating disorders related to apoe |
| 05/16/2002 | CA2425829A1 Proteases |
| 05/16/2002 | CA2425245A1 Novel compounds for treatment of cardiac arrhythmia synthesis, and methods of use |
| 05/16/2002 | CA2421154A1 Peroxisome proliferator activated receptor alpha agonists |
| 05/15/2002 | EP1205754A2 Method for screening plant extracts for active ingredients |
| 05/15/2002 | EP1205549A1 Gene expressed specifically in human fetal heart muscle |
| 05/15/2002 | EP1205478A1 p38MAP KINASE INHIBITORS |
| 05/15/2002 | EP1205477A1 Mutual prodrug of amlodipine and atorvastatin |
| 05/15/2002 | EP1205191A1 Targeted modification of intracellular compounds |
| 05/15/2002 | EP1205182A2 Adenosine as antithrombotic |
| 05/15/2002 | EP1205181A2 Composition and method for parenteral administration of ibuprofen D, L-or L-Lysine salt |
| 05/15/2002 | EP1204764A2 Methods of screening for angiogenesis modulators |
| 05/15/2002 | EP1204760A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 05/15/2002 | EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
| 05/15/2002 | EP1204747A1 G protein-coupled receptor expressed in brain |
| 05/15/2002 | EP1204669A1 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204663A1 Novel spiro compounds |
| 05/15/2002 | EP1204656A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride |
| 05/15/2002 | EP1204655A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/15/2002 | EP1204649A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 05/15/2002 | EP1204646A1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 05/15/2002 | EP1204641A1 4-aminopiperidine derivatives of tetrahydronaphthalene, chromans and thiochromans |
| 05/15/2002 | EP1204626A1 Ether compounds, compositions, and uses thereof |
| 05/15/2002 | EP1204430A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 05/15/2002 | EP1204429A2 Sustained release formulation of a peptide |
| 05/15/2002 | EP1204419A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 05/15/2002 | EP1204414A2 Use of morphinan derivates as medicines |
| 05/15/2002 | EP1204408A2 An improved form of form i celiprolol hydrochloride |
| 05/15/2002 | EP1204407A2 Implantable active ingredient depot |
| 05/15/2002 | EP1167360A9 Human chymase inhibitors |
| 05/15/2002 | EP1082028B1 Matthiola seed oil, mixtures containing it and use thereof |
| 05/15/2002 | EP0778833B1 Endothelin receptor antagonists |
| 05/15/2002 | EP0751775B1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives |
| 05/15/2002 | EP0748314B1 Tetrasubstituted imidazole derivatives, method for preparing the same, use thereof as drugs, and pharmaceutical compositions containing the same |
| 05/15/2002 | CN1349530A 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/15/2002 | CN1349525A Di-aryl acid derivatives as PPAR receptor ligands |
| 05/15/2002 | CN1349524A Renin inhibitors |
| 05/15/2002 | CN1349523A Novel lipoic acid derivatives, their prepn., and pharmaceutical compositions containing them |
| 05/15/2002 | CN1349510A Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349503A Renin ihibitors |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1349410A Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 05/15/2002 | CN1349409A Metabolic intervention with GLP-1 to improve the function of ischemic anc reperfused tissue |
| 05/15/2002 | CN1348815A Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| 05/15/2002 | CN1348803A Biological hypertension powder |
| 05/15/2002 | CN1348784A Kangzhi as one orally taken and externally applied medicine |
| 05/15/2002 | CN1348778A Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy |
| 05/15/2002 | CN1348771A Active animal protein liquid and its application |